Further dissection of the mechanism for how TTK can drive CA and genomic instability in specific breast cancer subtypes will be a key to understanding the correlations between high TTK levels and more aggressive/drug resistant breast tumors. The gene discussed is TTK; the disease is breast neoplasm.